NasdaqGS - Delayed Quote • USD
Align Technology, Inc. (ALGN)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:37 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 15 | 15 |
Avg. Estimate | 2.34 | 2.47 | 9.54 | 10.79 |
Low Estimate | 2.22 | 2.4 | 9.18 | 9.27 |
High Estimate | 2.46 | 2.56 | 9.85 | 11.47 |
Year Ago EPS | 2.22 | 2.14 | 8.61 | 9.54 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 14 | 14 |
Avg. Estimate | 1.04B | 1.02B | 4.1B | 4.49B |
Low Estimate | 1.03B | 988.4M | 4.04B | 4.35B |
High Estimate | 1.05B | 1.04B | 4.14B | 4.6B |
Year Ago Sales | 1B | 994.47M | 3.86B | 4.1B |
Sales Growth (year/est) | 3.90% | 2.90% | 6.30% | 9.50% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | 2.03 | 2.26 | 2.18 | 1.97 |
EPS Actual | 2.22 | 2.14 | 2.42 | 2.14 |
Difference | 0.19 | -0.12 | 0.24 | 0.17 |
Surprise % | 9.40% | -5.30% | 11.00% | 8.60% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 2.34 | 2.47 | 9.54 | 10.79 |
7 Days Ago | 2.38 | 2.43 | 9.28 | 10.51 |
30 Days Ago | 2.38 | 2.43 | 9.26 | 10.5 |
60 Days Ago | 2.38 | 2.43 | 9.26 | 10.5 |
90 Days Ago | 2.33 | 2.34 | 9.17 | 10.55 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 3 | 7 | 11 | 11 |
Up Last 30 Days | 4 | 8 | 12 | 12 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 5 | 1 | -- | -- |
Growth Estimates
CURRENCY IN USD | ALGN | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 5.40% | -- | -- | 5.40% |
Next Qtr. | 15.40% | -- | -- | 10.90% |
Current Year | 10.80% | -- | -- | 4.50% |
Next Year | 13.10% | -- | -- | 13.10% |
Next 5 Years (per annum) | 11.70% | -- | -- | 10.94% |
Past 5 Years (per annum) | 11.29% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Morgan Stanley: Overweight to Overweight | 4/25/2024 |
Reiterates | Piper Sandler: Overweight to Overweight | 4/25/2024 |
Maintains | Baird: Outperform to Outperform | 4/25/2024 |
Maintains | Stifel: Buy to Buy | 4/18/2024 |
Maintains | UBS: Neutral to Neutral | 4/15/2024 |
Maintains | Stifel: Buy to Buy | 3/15/2024 |
Related Tickers
DXCM DexCom, Inc.
124.34
-9.91%
BSX Boston Scientific Corporation
73.17
-0.12%
EW Edwards Lifesciences Corporation
86.43
-1.80%
TMDX TransMedics Group, Inc.
92.08
+3.17%
SYK Stryker Corporation
335.61
-0.46%
ABT Abbott Laboratories
107.53
+0.63%
INMD InMode Ltd.
17.14
+0.71%
MDT Medtronic plc
79.74
+0.62%
PODD Insulet Corporation
166.19
+1.23%
SWAV Shockwave Medical, Inc.
330.00
+0.31%